Sionna Therapeutics (SION) director granted options for 17,340 shares at $36.73
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sionna Therapeutics director Laurie Stelzer received a grant of non-qualified stock options covering 17,340 shares of common stock. The options have an exercise price of $36.73 per share and expire on June 16, 2036.
The option vests in full on the earlier of June 17, 2027 or the date of Sionna Therapeutics’ next annual meeting, subject to her continued service. Following this grant, Stelzer holds options for 17,340 underlying shares directly, reflecting a routine equity-based compensation award rather than an open-market share purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Stelzer Laurie
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 17,340 | $0.00 | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 17,340 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option shares granted: 17,340 shares
Exercise price: $36.73 per share
Expiration date: June 16, 2036
+2 more
5 metrics
Option shares granted
17,340 shares
Non-qualified stock option grant to director Laurie Stelzer
Exercise price
$36.73 per share
Exercise price of non-qualified stock option
Expiration date
June 16, 2036
Option expiration for director grant
Underlying common shares
17,340 shares
Common stock underlying the option award
Total options after grant
17,340 shares
Total derivative holdings following transaction
Key Terms
Non-Qualified Stock Option, grant/award acquisition, exercise price, expiration date, +1 more
5 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
exercise price financial
"conversion_or_exercise_price": "36.7300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-16T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"This option vests in full upon the earlier of June 17, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Sionna Therapeutics (SION) director Laurie Stelzer receive in this Form 4?
Laurie Stelzer received a grant of non-qualified stock options for 17,340 shares of Sionna Therapeutics common stock. These options are a form of equity compensation, not an open-market purchase or sale of existing shares.
What is the exercise price of Laurie Stelzer’s new SION stock options?
The options granted to Laurie Stelzer have an exercise price of $36.73 per share. She can choose to buy Sionna Therapeutics common stock at this fixed price once the options vest, if she decides to exercise them.
When do Laurie Stelzer’s Sionna Therapeutics stock options vest?
The options vest in full on the earlier of June 17, 2027 or the date of Sionna Therapeutics’ next annual meeting. Vesting is conditioned on Laurie Stelzer’s continued service through that vesting date.
When do the SION stock options granted to Laurie Stelzer expire?
The non-qualified stock options granted to Laurie Stelzer expire on June 16, 2036. After that expiration date she can no longer exercise the options to purchase Sionna Therapeutics common shares at the stated exercise price.